Tausif Butt - 07 May 2021 Form 4 Insider Report for ChemoCentryx, Inc.

Role
EVP, Chief Operating Officer
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
07 May 2021
Net transactions value
+$120,241
Form type
4
Filing time
10 May 2021, 19:48:47 UTC
Next filing
16 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCXI Common Stock Purchase $120,241 +10,870 $11.06 10,870 07 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $11.02 to $11.12 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.